New HIV guidelines offer adverse effects data.
The 'Guidelines for Using Antiretroviral Agents Among HIV-Infected Adults and Adolescents,' which are recommendations of the Panel on Clinical Practices for Treatment of HIV, have been updated with additional information linking the use of antiretroviral therapy to chronic diseases and adverse events.
D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D017410:Practice Guidelines as Topic; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors